If approved, how will MDMA-assisted therapy impact clinical psychiatry? The CEO of Lykos Therapeutics shares her thoughts.
Amy Emerson
Advertisement
Ms Emerson is the CEO Of Lykos Therapeutics.
Articles by Amy Emerson
Advertisement
Latest Updated Articles
MDMA-Assisted Therapy for PTSD: A Conversation With Amy Emerson, CEO of Lykos TherapeuticsPublished: June 3rd 2024 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Evidence-Based Psychotherapy and Psychopharmacology for Mood Disorders: A Conversation With Holly A. Swartz, MD
2
Can the Initial Antipsychotic Influence Years of Weight Gain?
3
New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms
4
How to Approach Conversations With Adult Patients Who Might Have ADHD: New Tools and Insights
5
